Author:
Serper Marina,Evon Donna M.,Stewart Paul W.,Lok Anna S.,Amador Jipcy,Reeve Bryce B.,Golin Carol E.,Fried Michael W.,Reddy K. Rajender,Sterling Richard K.,Sarkar Souvik,Di Bisceglie Adrian M.,Lim Joseph K.,Nelson David R.,Reau Nancy
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. Lo Re V, 3rd, Teal V, Localio AR, Amorosa VK, Kaplan DE, Gross R. Relationship between adherence to hepatitis C virus therapy and virologic outcomes: a cohort study. Ann Intern Med. 2011;155(6):353-60
2. AASLD-IDSA. Recommendations for testing, managing, and treating hepatitis C.
http://www.hcvguidelines.org
. Accessed June 30, 2019.
3. Guidelines for the screening, care and treatment of persons with chronic hepatitis C infection. Updated version, April 2016,
https://www.who.int/hepatitis/publications/hepatitis-c-guidelines-2016/en/
. Accessed June 30, 2019.
4. Millman AJ, Ntiri-Reid B, Irvin R, Kaufmann MH, Aronsohn A, Duchin JS, et al. Barriers to Treatment Access for Chronic Hepatitis C Virus Infection: A Case Series. Top Antivir Med. 2017;25(3):110-3.
5. Ooka K, Connolly JJ, Lim JK. Medicaid Reimbursement for Oral Direct Antiviral Agents for the Treatment of Chronic Hepatitis C. Am J Gastroenterol. 2017;112(6):828-32.
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献